Marwan Bukhari (@drdj) profile picture

director of medical education, rheumatologist and epidemiologist , liking sci fi and tolerating marvel

North West, England
Joined January 2009
Photo by Marwan Bukhari (@drdj)Photo by Marwan Bukhari (@drdj)Photo by Marwan Bukhari (@drdj)Photo by Marwan Bukhari (@drdj)Photo by Marwan Bukhari (@drdj)Photo by Marwan Bukhari (@drdj)Photo by Marwan Bukhari (@drdj)Photo by Marwan Bukhari (@drdj)Photo by Marwan Bukhari (@drdj)Photo by Marwan Bukhari (@drdj)
Marwan Bukhari retweeted
The first panel discussion of today explores ‘how do we better promote the quality of medical training?’. We are eager to hear from several panellists as well as questions posed from other delegates.
1
1
1
430
Still a chance to sign up to our last MorBLIME session of the year, coaching and mentoring excellence for education leaders. Dec 5th York mededleaders.co.uk/event/mor…
3
4
692
That was an amazing and inspirational day with the Doctors Training Team #Balance #Purpose #Development #DoctorsTraining
5
10
2
38
5,245
Marwan Bukhari retweeted
Happy #WorldASDay2024 to any #physiotherapists #rheumatology consultants/ doctors & patients who follow me. Check out resources from @NASSexercise nass.co.uk & @AStretch_Physio - more retweets to follow @BfwMsk @TherapiesRLI @NassLancaster @BlackpoolHosp @UHMBT
Happy #WorldASDay2024 from all of us from ⁦@AStretch_Physio⁩ to all our colleagues helping diagnose, treat & support and even more so our patients across the UK & the 🌍 Here is a top tip from the marvellous Mo Motion @MotionMop #axialSpA #ankylosingspondylitis #exercise
2
5
11
1,428
The team @DEMEC23 representing @MedEdLeaders and all enjoying the conference #ValuingMedEd #TeamWorkMakestheDreamWork
1
4
1
21
2,466
We are delighted to be @DEMEC23 promoting our small grant call on the theme of #ValuingMedEd In support of our 5th theme in our new best practice standards for valuing medical educators. Come and get a leaflet or check out our website for more details.
1
7
14
1,039
We are delighted to be here at #DEMEC23 please come and visit us at our stand to discuss all things #ValuingMedEd and meet the team and our regional reps
6
1
17
1,906
Marwan Bukhari retweeted
Excellent work by @DrGabrielFP @AliDuarteMD and colleagues published in @RheumJnl on multi-morbidity in #SLE 👏🏻 📑 academic.oup.com/rheumatolog… I know this will also be of interest to @gagan43 @ElenaNikiUK @Emanelfar77 too!
I'm happy to share a summary of our last paper from LUMEN 💡: 🧵1/8 🔥Patients with systemic #lupus erythematosus (#SLE) have 2-3 times higher mortality than the general population, and chronic conditions rather than #SLE activity are now the principal cause of death.
1
2
18
2,587
We're delighted to publish our first virtual roundtable! 👀 Watch our expert speakers discuss health inequalities in patients with rheumatic disease. A big thanks to speakers @GenQ5Lesley, @ErnestChoy1 and @RJ_Hollick, and moderator @drdj 🤗 👉 bit.ly/3MdeElB
5
12
1,872
Rheumatology is recruiting! We're looking for new Associate Editors with expertise in osteoarthritis, and paediatric and adolescent rheumatology. Come and join @drdj and the team @RheumJnl ✨ 👇 bit.ly/3PMEWfn
1
801
👆🏼#VEXAS syndrome is believed to only affect individuals above the age of 50. 😮We describe an early-onset case in a 23 y/o 🙎🏽‍♂️ with relapsing polychondritis. 🗝️Test for UBA1 mutations🧬, regardless of age, in adults with a VEXAS clinical phenotype. @ivette_pataki @RheumJnl
12
54
3
195
28,761
Our high impact article collection from Rheumatology and Rheumatology Advances in Practice is now available!🌟 Explore our most cited, downloaded, and discussed articles, open access until December! 👉bit.ly/3D1o3HW
8
2
15
9,375
Marwan Bukhari retweeted
203 Rheumatology Clinical trials .gov; after 30 mos 17% are unpublished. Published were more likely to be Phase 3 (57% v 29%) or have +primary outcome (65% vs 26%). Unpub authors cite ongoing preparation, sponsor issues, negative results https://nitter.cf/t.co/zSxt0W9ZhB
3
8
2,043
NEW: @Adeorlahmi et al. use real-world data from the Midlands Ankylosing Spondylitis Collaboration to investigate the effectiveness and safety of secukinumab in AS 🔍 👉 Secukinumab demonstrates clear benefit in AS, especially in TNFi-naïve patients. https://nitter.cf/t.co/jmnfXzjUtI
2
2
930
An interesting analysis of unpublished clinical trials for rheumatic diseases from @EBRheum & co. "Nearly one in five RCTs in rheumatology remain unpublished two years after trial completion..." 👀 academic.oup.com/rheumatolog… #AllTrials
9
1
22
3,747
NEW: Clark and Jawad present a case of sabre tibia in Paget’s disease. A) Sabre-like convexity of the right leg B) Cortical thickening, trabecular enlargement and bowing of the tibia C) Increased activity in the proximal two thirds via SPECT CT 👇 https://nitter.cf/t.co/EjCU0g06RP
2
5
1,431
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period - A Cross-sequential study based on COVAD surveys By @CoVADStudy Via @RheumJnl Congratulations to all team 👏🏼🥳🎉 academic.oup.com/rheumatolog…
7
18
55
5,037
NEW: @KearsleyFleet et al. compare the effectiveness of etanercept originator versus etanercept biosimilar amongst biologic-naïve RA patients treated in routine clinical-practice in the UK. Read now! ▶️ https://nitter.cf/t.co/71uPOlARmW
2
3
1,107
✨We’re thrilled to announce the winners of our Trainee Publishing Programme✨ A huge congratulations to Shivani Gor, @sharpcharlotte, Pallavi Shamdasani, Lauren Huckerby and @cristianasieiro! 🤩 Explore the winning papers 👇 https://nitter.cf/t.co/60tZTFAJyO
1
5
3
17
13,399